by 
The enteral nutrition market is in trends by technological innovations. Enteral nutrition refers to delivery of nutritional formulas into the gastrointestinal tract via a tube inserted through the nose or abdominal wall. It provides nutrition to patients who are unable to consume food by mouth, or who are malnourished or underweight. Enteral nutrition is used to deliver balanced nutrition to those suffering from chronic medical conditions including cancer, gastrointestinal disorders, neurological disorders and severe burns.
The global enteral nutrition market is estimated to be valued at US$ 3.1 Bn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030.
Enteral nutrition serves as an alternative to parenteral nutrition for patients who have a functioning gastrointestinal tract. Key advantages include ease of administration through tubes placed into stomach or small intestine, lower risk of infections, and cost effectiveness as compared to parenteral nutrition. Rising prevalence of malnutrition, chronic diseases and disorders requiring tube feeding is driving demand for enteral nutrition globally.
Key Takeaways
Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP.
The growing demand for clinical nutrition products for chronic diseases management and rise in preterm births rate are major factors propelling the demand for enteral nutrition. According to WHO, 15 million babies are born preterm each year and approximately 1 million babies die each year due to complications from preterm birth. This is expected to boost the demand for specialized enteral formulas.
North America dominates the enteral nutrition market due to high healthcare spending and presence of major players. However, Asia Pacific exhibits lucrative growth opportunities owing to increasing healthcare expenditure, large patient pool and rising incidence of chronic diseases in developing countries like India and China. Advancements in tube feeding devices and introduction of disease specific formulas are also expanding use of enteral nutrition globally.
Market key trends
One of the key trends in the enteral nutrition market is the shift towards advanced and personalized formulas with disease specific formulations. Formula manufacturers are focusing on developing formulations tailored for cancer, diabetes, renal disorders etc. For instance, Abbott launched Glucerna, a diabetes-specific formula with specialized carbohydrates. Similarly, disease specific formulas are available for conditions like pulmonary disorders, renal failure, hepatic disorders etc. This shift ensures optimal nourishment and facilitates faster recovery.
Porter’s Analysis
Threat of new entrants: New companies find it difficult to enter the enteral nutrition market due to high costs associated with R&D, manufacturing, marketing, and distribution of enteral nutrition products. Additionally, well-established players have strong brand reputation and customer base.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of various product options from different manufacturers. However, switching costs for buyers are low.
Bargaining power of suppliers: Suppliers have moderate to high bargaining power due to the availability of raw materials from few sources and stringent regulatory norms.
Threat of new substitutes: Threat from substitute products is low as there are limited substitutes for enteral nutrition products used for tube feeding.
Competitive rivalry: The enteral nutrition market witnesses high competitive rivalry due to the presence of numerous global and regional players competing on the basis of product offerings, quality, price, innovation, and customer service.
Geographically, North America dominates the enteral nutrition market and accounts for the largest share in terms of value due to increasing incidences of chronic diseases, rising healthcare expenditure, growing elderly population, and technological advancements in tube feeding products. Europe ranks second in terms of market share due to favorable reimbursements and increasing awareness about nutrition support therapy. Asia Pacific is expected to witness the fastest growth over the forecast period owing to expanding healthcare industry, large patient pool, and improving access to advanced treatments in emerging countries.
The fastest growing region in the enteral nutrition market is Asia Pacific owing to rising disposable incomes, increasing healthcare expenditure, growing disease prevalence, expanding medical tourism industry, developing healthcare infrastructure, and presence of less stringent regulations compared to developed regions. Penetration of international players through distribution agreements and acquisitions further supports market growth in Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
